Total Clarity Wealth Management’s Boston Scientific BSX Stock Holding History

Total Clarity Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-249	Closed	-$9K	–	310
2022 Q2	$9K	Buy	+249	New	+$10.1K	﹤0.01%	684
2022 Q1	–	Sell	-167	Closed	-$7K	–	296
2021 Q4	$7K	Hold	167	–	–	﹤0.01%	747
2021 Q3	$7K	Buy	+167	New	+$7.39K	﹤0.01%	746
2021 Q2	–	Sell	-167	Closed	-$6K	–	254
2021 Q1	$6K	Buy	+167	New	+$6.32K	﹤0.01%	645
2020 Q1	–	Sell	-167	Closed	-$8K	–	149
2019 Q4	$8K	Buy	+167	New	+$6.99K	0.01%	520

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Total Clarity Wealth Management's BSX Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of Boston Scientific (BSX) in Q3 2022, closing a stake of 249 shares — an estimated $9K sold.

Total Clarity Wealth Management first reported a position in BSX in Q4 2019 and held it in 5 quarters. The position peaked at $9K in Q2 2022. 864 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

Total Clarity Wealth Management reported no remaining Boston Scientific position as of Q3 2022 after selling out during the quarter.
Total Clarity Wealth Management sold 249 Boston Scientific shares in Q3 2022, an estimated $9K.
Total Clarity Wealth Management first reported a position in Boston Scientific in Q4 2019 and held it in 5 quarters.
Total Clarity Wealth Management's Boston Scientific position peaked at $9K in Q2 2022.
864 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.